Neurovascular Nugget_ Re-evaluating Thrombectomy in MEVO - Insights from DISTAL and ESCAPE-MeVO

"Given the methodological heterogeneity and distinct patient populations enrolled in the DISTAL and ESCAPE-MeVO trials, caution is warranted when attempting to synthesize or directly compare their findings. The disparate designs and inclusion criteria limit the cumulative interpretability of the results, necessitating independent evaluation of each study's conclusions. Furthermore, the following nuances necessitate careful consideration when interpreting each study's findings, as they may significantly influence the reader's understanding of the efficacy and safety of endovascular treatment for medium and distal vessel occlusions."🔴 Vessel Definition & Patient Population:DISTAL (Broader): Diluted EVT benefit due to inclusion of potentially less severe distal occlusions and exclusion of known EVT-responsive dominant M2s. Impact: Underestimation of EVT potential.ESCAPE-MeVO (Narrower): Targeted a more specific group, but chosen locations may have been less amenable to EVT or higher risk. Impact: Potential for negative result.Overall Impact: Differences may explain DISTAL's neutral result vs. ESCAPE-MeVO's harm signal.🔴 Time Window:DISTAL (Longer - 24h): Allowed more patients but increased irreversible damage and spontaneous recanalization. Impact: Diluted treatment effect.ESCAPE-MeVO (Shorter - 12h): Enriched for potentially responsive patients but may have missed others who could benefit. Impact: Potentially missed benefit, workflow negated any potential benefit.Imaging (ESCAPE-MeVO):🔴 Salvageable Tissue Required: Focused EVT on those with potential benefit, but specific criteria could have biased selection. Impact: Potential exclusion of treatable patients.🔴 Device Mandate (ESCAPE-MeVO):Solitaire X Only: Reduced procedural variability but limited operator choice and real-world applicability. Impact: Potential for suboptimal device selection, skewed real-world applicability.🔴 Mortality (ESCAPE-MeVO):Increased Mortality Signal: Serious concern suggesting potential harm in this specific context. Impact: Strong argument against routine EVT in this population.🔴 Workflow Times:🟢 Prolonged Times (Both, esp. ESCAPE-MeVO): Delays could negate EVT benefits due to irreversible damage. Impact: Undermined potential efficacy.🟢Spontaneous Recanalization (ESCAPE-MeVO):Recanalization Before EVT: Unnecessary EVT in some, diluting treatment effect and cumulating risk. Impact: Obscured potential benefit.